Aquestive Therapeutics furnishes investor presentations; no material new disclosures

Aquestive Therapeutics, Inc.

Filed Form 8-K on September 9, 2024 to disclose investor presentation and H.C. Wainwright conference slides.
Presentations provided as Exhibit 99.1 and 99.2; no specific financial updates or guidance changes were included in the filing.
Information is furnished under Regulation FD and not deemed filed for SEC liability purposes.
No material new business developments, earnings data, or strategic actions were reported.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.